AR009435A1 - Derivado de guanaidina n-[carbonil(heteroaril-substituida de 5 miembros)], un inhibidor del intercambiador de na+/h+ que comprende dicho derivado y usosen la fabricacion de medicamentos. - Google Patents
Derivado de guanaidina n-[carbonil(heteroaril-substituida de 5 miembros)], un inhibidor del intercambiador de na+/h+ que comprende dicho derivado y usosen la fabricacion de medicamentos.Info
- Publication number
- AR009435A1 AR009435A1 ARP970105802A AR009435A1 AR 009435 A1 AR009435 A1 AR 009435A1 AR P970105802 A ARP970105802 A AR P970105802A AR 009435 A1 AR009435 A1 AR 009435A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- derivative
- alkyl group
- inhibitor
- lower alkyl
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 102000050381 Na+/H+ exchanger Human genes 0.000 abstract 2
- 108091006672 Sodium–hydrogen antiporter Proteins 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002357 guanidines Chemical class 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Un derivado de guanidina n-[carbonil(heteroaril-substituida de 5 miembros)], un inhibidor representado por la formula general (I) o una salfarmacéuticamente aceptable del mismo, el cual es util como inhibidor del intercambiador de Na+/H+ en la prevencion, tratamiento o diagnostico deenfermedades tales como la hipertension, la arritmia, la angina de pecho, la infartacion miocárdica, la arteriosclerosis, las complicaciones diabéticas ysimilares en las cuales está relacionado elintercambiador de Na+/H+. El derivado posee la formula (1) donde (2):R1 es un grupo arilo substituido con unsubstituyente seleccionado del grupo que consiste de un dialquilamino inferior- alquileno inferior-O-, un dialquilamino inferior-alquileno inferior-CONH-, unhetero anillo saturado conteniendo nitrogeno-CONH- que puede ser substituido con un grupo alquilo inferior sobre el átomo de nitrogeno en el anillo y unhetero anillo saturado conteniendo un nitrogeno-alquileno inferior-O- que puede ser substituido con un grupo alquilo inferior sobre el átomo de nitrogeno en elanillo, y un grupo de alquilo inferior que puede ser subtituido con un átomo de halogeno. R2: es un grupo alquilo inferior que puede estar sustituido con unátomo de halogeno.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33563896 | 1996-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR009435A1 true AR009435A1 (es) | 2000-04-12 |
Family
ID=18290844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105802 AR009435A1 (es) | 1996-12-16 | 1997-12-10 | Derivado de guanaidina n-[carbonil(heteroaril-substituida de 5 miembros)], un inhibidor del intercambiador de na+/h+ que comprende dicho derivado y usosen la fabricacion de medicamentos. |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR009435A1 (es) |
| AU (1) | AU5411998A (es) |
| WO (1) | WO1998027061A1 (es) |
| ZA (1) | ZA9711102B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU739403B2 (en) | 1998-02-27 | 2001-10-11 | Pfizer Products Inc. | N-((substituted five-membered di- or triaza diunsaturated ring)carbonyl) guanidine derivatives for the treatment of ischemia |
| US6852733B2 (en) | 2000-04-28 | 2005-02-08 | Pfizer Inc. | Sodium-hydrogen exchanger type 1 inhibitor |
| JP4716547B2 (ja) * | 2000-08-10 | 2011-07-06 | 住友精化株式会社 | ２−フェニルチアゾール類の製造方法 |
| FR2842524B1 (fr) * | 2002-07-16 | 2005-04-22 | Aventis Pharma Sa | Compositions pharmaceutiques contenant un derive de 3-guanidinocarbonyl-1-heteroaryl-pyrrole, leur procede de preparation a titre de medicaments |
| EP1866293A1 (en) * | 2005-03-31 | 2007-12-19 | UCB Pharma, S.A. | Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| EP1991528A2 (en) * | 2006-01-18 | 2008-11-19 | Siena Biotech S.p.A. | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
| KR100863336B1 (ko) * | 2006-09-29 | 2008-10-15 | 한국화학연구원 | 신규 옥사졸-4-카르보닐구아니딘 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 허혈성 심장질환의 예방 및 치료용 약학적 조성물 |
| KR100820173B1 (ko) * | 2007-03-12 | 2008-04-08 | 한국화학연구원 | 4-메틸이미다졸-5-카보닐구아니딘 유도체, 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 유효성분으로함유하는 허혈성 심장질환의 예방 및 치료용 약학적 조성물 |
| MX2009010558A (es) * | 2007-04-03 | 2009-10-22 | Du Pont | Fungicidas de benceno sustituido. |
| EP2844634B1 (en) * | 2012-05-03 | 2021-04-14 | DSM IP Assets B.V. | Process for the preparation of intermediate compounds for preparing vitamin b6 |
| MX2023012060A (es) | 2021-04-13 | 2024-01-22 | Nuvalent Inc | Heterociclos con sustitucion amino para tratar canceres con mutaciones de egfr. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE795808A (fr) * | 1972-02-24 | 1973-08-22 | Beecham Group Ltd | Amidazoles polysubstitues |
| JPS63192755A (ja) * | 1987-02-06 | 1988-08-10 | Fujisawa Pharmaceut Co Ltd | ２−フエニルアゾ−ル誘導体およびその塩 |
| JPH0692375B2 (ja) * | 1987-12-16 | 1994-11-16 | 四国化成工業株式会社 | カルバモイルイミダゾールの合成方法 |
| FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
-
1997
- 1997-12-10 ZA ZA9711102A patent/ZA9711102B/xx unknown
- 1997-12-10 AR ARP970105802 patent/AR009435A1/es unknown
- 1997-12-15 AU AU54119/98A patent/AU5411998A/en not_active Abandoned
- 1997-12-15 WO PCT/JP1997/004605 patent/WO1998027061A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998027061A1 (en) | 1998-06-25 |
| ZA9711102B (en) | 1998-08-13 |
| AU5411998A (en) | 1998-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3022571T3 (en) | Use of sulfonamides as drug and new sulfonamides | |
| PE20011001A1 (es) | Compuestos heterociclicos como inhibidores del intercambio de sodio/protones | |
| AR009435A1 (es) | Derivado de guanaidina n-[carbonil(heteroaril-substituida de 5 miembros)], un inhibidor del intercambiador de na+/h+ que comprende dicho derivado y usosen la fabricacion de medicamentos. | |
| CY1112800T1 (el) | Η χρηση υποκαθιστουμενων κυανοπυρρολιδινων για τη θεραπεια της υπερλιπιδαιμιας | |
| KR970061865A (ko) | 신규 치환된 구아니딘 유도체, 그의 제조방법, 및 그의 약제학적 용도 | |
| FR2358891A1 (fr) | Composes heterocycliques contenant un azote, utilise comme agents analgesiques et anti-inflammatoires | |
| KR900700435A (ko) | 신규아민류 및 그 용도 | |
| KR960014102A (ko) | 인돌로일구아니딘 유도체 | |
| ES2150445T3 (es) | Medicamento anti-isquemico. | |
| KR910021375A (ko) | 4-(디-n-프로필)아미노-6-아미노카보닐-1,3,4,5-테트라하이드로벤즈[cd]인돌의 결정형 염 | |
| KR890005088A (ko) | 4- 아미노피리딘 유도체 및 그의 산 부가염 | |
| ATE136018T1 (de) | Substituierte carbonsäurederivate | |
| GB1228736A (es) | ||
| ATE262518T1 (de) | Neuartige isoquinolin-derivate oder salze davon | |
| KR910009270A (ko) | 15-케토-프로스타글란딘 화합물을 이용한 심기능장애의 치료방법 | |
| DK0719766T3 (da) | 1,4-Benzoxazinderivat, farmaceutisk præparat indeholdende samme og anvendelse deraf | |
| DK0397031T3 (da) | Hidtil ukendte phenylalkansyreestere | |
| KR960029319A (ko) | 4-아미노벤조일구아니딘 유도체 | |
| GB1262292A (en) | Novel thiazoline derivatives, the preparation thereof and compositions containing the same | |
| KR960703595A (ko) | 항우울제(antidepressant) | |
| KR890009876A (ko) | 9-아실아미노- 테트라히드로아크리딘 유도체 및 그 유도체를 활성성분으로 포함하는 기억력 촉진제 | |
| SU727643A1 (ru) | -Замещенные амиды 4-антипирилоксаминовой кислоты,про вл ющие сахароснижающую активность | |
| IE39247L (en) | Substituted benzamides | |
| KR930004250A (ko) | 치환된 1-페닐-1-벤조일아미노-5-아미노펜탄, 그의 제조 방법 및 용도 | |
| GB1531091A (en) | Pharmaceutical combination preparations |